ELITE study raises losartan's profile in heart failure therapy debate.
D000368:Aged; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D019808:Losartan; D008297:Male; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D013777:Tetrazoles / Q000627:therapeutic use*
D001713:Biphenyl Compounds; D002317:Cardiovascular Agents; D007093:Imidazoles; D013777:Tetrazoles; D019808:Losartan